Exhibit 10.1


 


SECURITIES
PURCHASE AGREEMENT


 


This
Securities Purchase Agreement (“Agreement”) is made as of April 25, 2018, by and between MYOS RENS Technology
Inc., a Nevada corporation (the “Company”), and each of the purchasers who execute the Purchaser Signature
Page hereto (the “Purchaser”).


 


R E C I T A L S


 


A.          The
Company desires to obtain funds from each Purchaser in order to provide working capital for marketing, research and development
expansion and to further the operations of the Company.


 


B.          The
Company is offering shares of its common stock, $0.001 par value per share (the “Common Stock” and, the shares
of Common Stock offered herein, being sometimes referred to herein as the “Shares” or the “Securities”).
The purchase price (the “Purchase Price”) shall be $1.24 per Share.


 


C.          Purchasers
understand that there is a great deal of risk, illiquidity and uncertainty in the purchase of the Shares herein, and that no assurance
can be made that the Company will complete its business plan or, if completed, that it will be successful in doing so.  Purchasers
had the opportunity to receive and examine all of the Company’s SEC Reports (as defined below), including, without limitation,
any risk factors therein and understand that an investment herein entails a high degree of risk and illiquidity, including the
possible loss of Purchaser’s entire investment.


 


D.          The
offering of Shares is being made directly by the Company to accredited investors only, under Section 4(a)(2) of Rule 506 of Regulation
D promulgated under, the Securities Act of 1933, as amended (the “Securities Act”), on a “best efforts”
basis.


  


E.          Until
the Closing, the Company may reject any subscriptions in whole or in part or elect not to close, for any reason or for no reason
and shall return funds to the Purchaser to the extent of funds tendered for subscriptions which have not been accepted.  The
offering will remain open until May 1, 2018, unless earlier terminated by the Company, unless extended for 30 days at the sole
discretion of the Company (which extension may be made without the consent of Purchasers). The maximum amount to be sold hereunder
shall not exceed $1.0 million.


 


AGREEMENT


 


It
is agreed as follows:


 


1.           PURCHASE
AND SALE OF SHARES.


 


1.1         Purchase
and Sale.  In reliance upon the representations and warranties of the Company and each Purchaser contained herein
and subject to the terms and conditions set forth herein, at Closing, each Purchaser shall purchase, and the Company shall sell
and issue to each Purchaser, the number of Shares set forth on the signature page annexed to this Agreement as executed by such
Purchaser (the “Purchaser Signature Page”), issued in such Purchaser’s name for the Purchase Price.


 


2.           CLOSING.


 


2.1          Date
and Time.  The sale of Shares will take place in one or more closings (“Closing”), subject to
the satisfaction of all the parties hereto of their obligations herein.   Each Closing shall take place at the
offices of the Company’s counsel or at such other place as the parties may agree (each, a “Closing Date”)
as soon as practicable after the Purchase Price for the Shares have been received by the Company and the corresponding subscription
documents have been delivered to the Company by the Purchasers.


 






     

     


    

 


2.2         Binding
Subscriptions.  Purchasers acknowledge and agree that their subscriptions are irrevocable and binding commitments
on the part of the Purchaser once their funds have been tendered to the Company and their subscription documents have been
delivered to the Company.


 


3.          REPRESENTATIONS
AND WARRANTIES OF THE COMPANY.


 


As
a material inducement to each Purchaser to enter into this Agreement and to purchase the Shares to assist in placing the offering,
the Company represents and warrants that the following statements are true and correct in all material respects as of the date
hereof and will be true and correct in all material respects at Closing, except as expressly qualified or modified herein.  


 


3.1          Organization
and Good Standing.  The Company is a corporation duly organized, validly existing, and in good standing under the
laws of the State of Nevada and has full corporate power and authority to enter into and perform its obligations under this Agreement,
and to own its properties and to carry on its business in all jurisdictions as presently conducted and as proposed to be conducted.  The
Company and its subsidiaries (the “Subsidiaries”) have all government and other licenses and permits and authorizations
to do business in all jurisdictions where their activities require such license, permits and authorizations, except where failure
to obtain any such license, permit or authorization will not have a material adverse effect on the Company’s assets, properties,
financial condition, operating results or business of the Company taken as a whole other than an effect primarily or proximately
resulting from (A) changes in general economic or market conditions affecting the industry generally in which the Company operates,
which changes do not disproportionately affect the Company as compared to other similarly situated participants in the industry
in which the Company operates; (B) changes in applicable law or United States generally accepted accounting principles (“GAAP”);
and (C) acts of terrorism, war or natural disasters which do not disproportionately affect the Company (as such business is presently
conducted) (a “Material Adverse Effect”).


 


3.2          Capitalization.  As
of December 31, 2017, the Company is authorized to issue 12,000,000 shares of Common Stock, of which 6,667,271 shares were issued
and outstanding, and 500,000 shares of preferred stock authorized, none of which is or has been issued or outstanding or designated
or otherwise agreed to be issued or outstanding and none of which has been or is designated as a series or class with any specific
rights or privileges.   No further approval or authorization of any stockholder, the Board of Directors or others
is required for the issuance and sale of the Securities.


  


3.3          Authorization.  The
Company has full power and authority and has taken all requisite action on the part of the Company, its officers, directors and
stockholders necessary for (i) the authorization, execution and delivery of this Agreement and any other transaction documents
relating to this Agreement (collectively the “Transaction Documents”), (ii) the authorization of the performance
of all obligations of the Company hereunder or thereunder, and (iii) the authorization, issuance (or reservation for issuance)
and delivery of the Shares hereby.  The Transaction Documents constitute the legal, valid and binding obligations of
the Company, enforceable against the Company in accordance with their terms, subject to bankruptcy, insolvency, fraudulent transfer,
reorganization, moratorium and similar laws of general applicability, relating to or affecting creditors’ rights generally.


 


3.4          Valid
Issuance of Securities.  The Shares have been duly and validly authorized and, upon issuance, will be validly issued,
fully paid and non-assessable.  The Shares upon issuance are free and clear of any security interests, liens, claims
or other encumbrances, other than restrictions upon transfer under federal and state securities laws. The shares of each Subsidiary
are duly authorized, validly issued, fully paid and non assessable and held by the Company which has sole, and unencumbered marketable
title and is the sole owner.


 


3.5          Securities
Law Compliance.  Assuming the accuracy of the representations and warranties of each Purchaser set forth in Section
4 of this Agreement, the offer and sale of the Shares will constitute an exempted transaction under the Securities Act, and registration
of the Shares under the Securities Act for issuance herein is not required.  The Company shall make such filings as
may be necessary to comply with the Federal securities laws and the “blue sky” laws of any state in connection with
the offer and sale of the Securities, which filings will be made in a timely manner.


 






    	 	2	 



     


    

 


3.6         No
General Solicitation.  Neither the Company, nor any of its Affiliates, nor to Company’s knowledge, any person
acting on its or their behalf, has engaged in any form of general solicitation or general advertising (within the meaning of Regulation
D under the Securities Act) in connection with the offer or sale of the Securities.


 


3.7          SEC
Reports and Financial Statements.


      


3.7.1      The
Company has made available to each Purchaser through the SEC’ s EDGAR system accurate and complete copies (excluding copies
of exhibits) of each report, registration statement, and definitive proxy statement filed by the Company with the United States
Securities and Exchange Commission (“SEC” ) since December 31, 2011 (collectively, the “SEC Reports”
).  All statements, reports, schedules, forms and other documents required to have been filed by the Company with the
SEC have been so filed.  As of the time it was filed with the SEC (or, if amended or superseded by a filing prior to
the date of this Agreement, then on the date of such filing): (i) each of the SEC Reports complied in all material respects with
the applicable requirements of the Securities Act, or the Securities Exchange Act of 1934, as amended, as applicable; and (ii)
none of the SEC Reports contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading.


 


3.7.2      The
financial statements contained in the SEC Reports: (i) complied as to form in all material respects with the published rules and
regulations of the SEC applicable thereto at the time of filing and as of the date of each Closing; (ii) were prepared in accordance
with GAAP applied on a consistent basis throughout the periods covered (except as may be indicated in the notes to such financial
statements and, in the case of unaudited statements, as permitted by Form 10-Q of the SEC, and except that unaudited financial
statements may not contain footnotes and are subject to normal and recurring year-end audit adjustments which will not, individually
or in the aggregate, be material in amount); and (iii) fairly present, in all material respects, the financial position of the
Company as of the respective dates thereof and the results of operations of the Company for the periods covered thereby, subject,
in the case of unaudited financial statements, to normal, immaterial, year-end audit adjustments.  All adjustments considered
necessary for a fair presentation of the financial statements have been included.


 


 4.         REPRESENTATIONS AND WARRANTIES OF EACH PURCHASER.


 


 Each
Purchaser individually and not jointly hereby represents warrants and covenants with the Company as follows.  For the
avoidance of doubt, these warranties and representations are made to the Company as well as to its agents and representatives
and affiliates, as third party beneficiaries hereto:


 


4.1         Legal
Power.  Each Purchaser has the requisite individual, corporate, partnership, limited liability company, trust, or
fiduciary power, as appropriate, and is authorized, if such Purchaser is a corporation, partnership, limited liability company,
or trust, to enter into this Agreement, to purchase the Shares hereunder, and to carry out and perform its obligations under the
terms of this Agreement or any other Transaction Documents to which it is a party.


 


4.2         Due
Execution.  The execution and performance of the terms under this Agreement and the Accredited Investor Questionnaire
commencing on Page SP-2 appended at the end of this Agreement (the “Questionnaire”) and Purchaser Signature
Page hereto, have been duly authorized, if such Purchaser is a corporation, partnership, limited liability company, trust or fiduciary,
executed and delivered by such Purchaser, and, upon due execution and delivery by the Company, this Agreement will be a valid
and binding agreement of such Purchaser.


 


4.3         Access
to Information.  Each Purchaser understands that an investment in the Securities involves a high degree of risk
and illiquidity, including, risk of loss of their entire investment.  Each Purchaser also understands that the Company
has limited capital and is not profitable.  Each Purchaser represents that such Purchaser has been given access to the
Company for the purpose of obtaining such information as such Purchaser or its qualified representative has reasonably requested
in connection with the decision to purchase the Shares.  Each Purchaser represents that such Purchaser had the opportunity
to receive and review copies of the SEC Reports.  Each Purchaser represents that such Purchaser has been afforded the
opportunity to ask questions of the officers of the Company regarding its business prospects and the Shares, all as such Purchaser
or such Purchaser’s qualified representative have found necessary to make an informed investment decision to purchase the
Shares.


  






    	 	3	 



     


    

 


4.4         Restricted
Securities.


 


4.4.1      Each
Purchaser has been advised that none of the Securities have been registered under the Securities Act or any other applicable securities
laws and that the Shares are being offered and sold pursuant to Section 4(a)(2) of the Securities Act and/or Rule 506 of Regulation
D thereunder, and that the Company’s reliance upon Section 4(a)(2) and/or Rule 506 of Regulation D is predicated in part
on such Purchaser representations as contained herein (including, for avoidance of doubt, the Questionnaire).  Each
Purchaser acknowledges that the Securities will be issued as “restricted securities” as defined by Rule 144 promulgated
pursuant to the Securities Act.  None of the Securities may be resold in the absence of an effective registration statement
thereof under the Securities Act and applicable state securities laws unless, in the opinion of counsel reasonably satisfactory
to the Company, an applicable exemption from registration is available.


 


4.4.2      Each
Purchaser represents that such Purchaser is acquiring the Shares for such Purchaser’s own account, and not as nominee or
agent, for investment purposes only and not with a view to, or for sale in connection with, a distribution, as that term is used
in Section 2(11) of the Securities Act, in a manner which would require registration under the Securities Act or any state securities
laws.


 


4.4.3      Each
Purchaser understands and acknowledges that the certificates representing the Shares will bear substantially the following legend:


 


“THE
SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”),
OR APPLICABLE STATE LAW, AND NO INTEREST THEREIN MAY BE SOLD, DISTRIBUTED, ASSIGNED, OFFERED, PLEDGED OR OTHERWISE TRANSFERRED
UNLESS (i) THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS COVERING ANY SUCH TRANSACTION
INVOLVING SAID SECURITIES, (ii) THE COMPANY RECEIVES AN OPINION OF LEGAL COUNSEL REASONABLY SATISFACTORY TO THE COMPANY STATING
THAT SUCH TRANSACTION IS EXEMPT FROM REGISTRATION, OR (iii) THE COMPANY OTHERWISE SATISFIES ITSELF THAT SUCH TRANSACTION IS EXEMPT
FROM REGISTRATION.”


 


4.4.4      Each
Purchaser acknowledges that an investment in the Shares is not liquid and is transferable only under limited conditions.  Each
Purchaser acknowledges that such Securities must be held indefinitely unless they are subsequently registered under the Securities
Act or an exemption from such registration is available.  Each Purchaser is aware of the provisions of Rule 144 promulgated
under the Securities Act, which permits limited resale of restricted securities subject to the satisfaction of certain conditions
and that such Rule is not now available and, in the future, may not become available for resale of any of the Securities and that
the Company is an issuer subject to Rule 144(i) under the Securities Act.  Each Purchaser is an “accredited investor”
as defined under Rule 501 under the Securities Act.


 


4.4.5      The
representations made by each Purchaser on the Questionnaire (commencing on page SP-2 appended at the end hereof) and Purchaser
Signature Page are true and correct.


 


4.5         Purchaser
Sophistication and Ability to Bear Risk of Loss.  Each Purchaser acknowledges that it is able to protect its interests
in connection with the acquisition of the Securities and can bear the economic risk of investment in such Securities without producing
a material adverse change in such Purchaser’s financial condition.  Each Purchaser, either alone or with such
Purchaser’s representative(s), otherwise has such knowledge and experience in financial or business matters that such Purchaser
is capable of evaluating the merits and risks of the investment in the Securities.


 






    	 	4	 



     


    

 


4.6         Purchases
by Groups.  Each Purchaser represents, warrants and covenants that it is not acquiring the Shares as part of a group
within the meaning of Section 13(d)(3) of the 1934 Act or otherwise purchasing with intent to control voting over the Company.


 


4.7         Independent
Investigation.  Each Purchaser in making his decision to purchase the Shares herein, has relied solely upon an independent
investigation made by him and his legal, tax and/or financial advisors and, is not relying upon any oral representations of the
Company.


 


4.8         No
Advertising.  Each Purchaser has not received any general solicitation or advertising regarding the offer of the
Shares.


 


4.9         Certain
Trading Activities.  Each Purchaser has not directly or indirectly, nor has any person acting on behalf of or pursuant
to any understanding with such Purchaser, engaged in any transactions in the securities of the Company (including, without limitation,
any short sales involving the Company’s securities) since the time that such Purchaser was first contacted by the Company
regarding the investment in the Company contemplated by this Agreement.  Each Purchaser covenants that neither it nor
any person acting on its behalf or pursuant to any understanding with it will engage in any transactions in the securities of
the Company (including short sales) prior to the time that the transactions contemplated by this Agreement are publicly disclosed.


 


5.           COVENANTS OF THE COMPANY AND PURCHASER


 


5.1          Use of Proceeds.  The Company intends to employ the net proceeds from the purchase and sale
of the Shares for purposes of its marketing, research and development, expansion as well as general working capital, and to further
the operations of the Company.


 


5.2         Registration
Rights.  For purposes of this Section 5.2, all references to the Purchaser shall be deemed to mean and include,
the Purchaser and its respective assigns as holders of Registrable Securities (as defined in Section 5.2.1(b) below).  The
Company shall use commercially reasonable efforts to file a registration statement with the SEC pursuant to the Securities Act
with respect to the re-sale of all Shares within 30 days of the first closing of the offering of the sale of Shares hereby and
shall use commercially reasonable efforts to obtain effectiveness of such registration statement within 90 calendar days of the
first Closing of the offering of the Shares hereby.


 


5.2.1      Notice
of Registration.  If the Company shall determine to register any of its securities under the Securities Act in connection
with the public offering of such securities, either for its own account or the account of a security holder, other than (A) a
registration relating to employee benefit plans, (B) a registration relating to a Rule 145 transaction or similar transaction, and
(C) a registration on any form that does not include substantially the same information as could be required to be included in
a registration statement covering the sale of Registrable Securities, the Company will:


 


(a)     promptly
give to each Purchaser written notice thereof; and


 


(b)     use
commercially reasonable efforts to include in such registration (and any related qualification under blue sky laws or other compliance),
and in any underwriting involved therein, all the Registrable Securities specified in a written request or requests, made within
twenty (20) days after receipt of such written notice from the Company, by any such Purchaser, except as set forth in Section
5.2.2 below.  In the event that the Company decides for any reason not to complete the registration of securities other
than Registrable Securities as part of an underwritten public offering it shall specify that such Registrable Securities are to
be included in the underwriting on the same terms and conditions as the securities otherwise being sold through underwriters under
such registration.


 


“Registrable
Securities” means the Shares which have not been registered under the Securities Act pursuant to an effective registration
statement (a “Registration Statement”) filed thereunder and which are not then eligible for resale by the holder
thereof pursuant to Rule 144, the following, unless the Company’s underwriters deem that registration of such shares might
materially injure an offering by the Company.


 






    	 	5	 



     


    

 


5.2.2      Registration
Process.  In connection with the registration of the Registrable Securities pursuant to Section 5.2.1, the Company
shall:


 


(a)      Prepare
and file with the SEC the Registration Statement and such amendments (including post effective amendments) to the Registration
Statement and supplements to the prospectus included therein (a “Prospectus”) as the Company may deem necessary
or appropriate and take all lawful action such that the Registration Statement and any amendment thereto does not, when it becomes
effective, contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary
to make the statements therein, not misleading and that the Prospectus forming part of the Registration Statement, and any amendment
or supplement thereto, does not at any time during the period commencing on the effective date of the Registration Statement and
ending on the date on which all of the Registrable Securities may be sold to the public without registration under the Securities
Act in reliance on Rule 144 (the “Registration Period”) include an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading;


 


(b)      Comply
with the provisions of the Securities Act with respect to the Registrable Securities covered by the Registration Statement until
the earlier of (i) such time as all of such Registrable Securities have been disposed of in accordance with the intended methods
of disposition by each Purchaser as set forth in the Prospectus forming part of the Registration Statement or (ii) the date on
which the Registration Statement is withdrawn;


 


(c)      Furnish
to each Purchaser and its legal counsel identified to the Company (i) promptly after the same is prepared and publicly distributed,
filed with the SEC, or received by the Company, one copy of the Registration Statement, each Prospectus, and each amendment or
supplement thereto, and (ii) such number of copies of the Prospectus and all amendments and supplements thereto and such other
documents, as the Purchaser may reasonably request in order to facilitate the disposition of the Registrable Securities;


 


(d)     Register
or qualify the Registrable Securities covered by the Registration Statement under such securities or “blue sky” laws
of such jurisdictions as the Purchasers reasonably request, (ii) prepare and file in such jurisdictions such amendments (including
post effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain the effectiveness
thereof at all times during the Registration Period, (iii) take all such other lawful actions as may be necessary to maintain
such registrations and qualifications in effect at all times during the Registration Period, and (iv) take all such other lawful
actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto to (A) qualify to do business
in any jurisdiction where it would not otherwise be required to qualify, (B) subject itself to general taxation in any such jurisdiction
or (C) file a general consent to service of process in any such jurisdiction;


 


(e)      As
promptly as practicable after becoming aware of such event, notify each Purchaser of the occurrence of any event, as a result
of which the Prospectus included in the Registration Statement, as then in effect, includes an untrue statement of a material
fact or omits to state a material fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading, and promptly prepare an amendment to the Registration Statement
and supplement to the Prospectus to correct such untrue statement or omission, and deliver a number of copies of such supplement
and amendment to each Purchaser as such Purchaser may reasonably request;


 


(f)      As
promptly as practicable after becoming aware of such event, notify each Purchaser (or, in the event of an underwritten offering,
the managing underwriters) of the issuance by the SEC of any stop order or other suspension of the effectiveness of the Registration
Statement and take all lawful action to effect the withdrawal, rescission or removal of such stop order or other suspension;


 


(g)     Take
all such other lawful actions reasonably necessary to expedite and facilitate the disposition by the Purchaser of its Registrable
Securities in accordance with the intended methods therefor provided in the Prospectus which are customary under the circumstances;


 






    	 	6	 



     


    

 


(h)     In
the event of an underwritten offering, promptly include or incorporate in a Prospectus supplement or post-effective amendment
to the Registration Statement such information as the underwriters reasonably agree should be included therein and to which the
Company does not reasonably object and make all required filings of such Prospectus supplement or post-effective amendment as
soon as practicable after it is notified of the matters to be included or incorporated in such Prospectus supplement or post-effective
amendment;


 


(i)       In
connection with any underwritten offering, deliver such documents and certificates as may be reasonably required by the underwriters;
and


 


(j)       Cooperate
with the Purchasers to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be
sold pursuant to the Registration Statement, which certificates shall, if required under the terms of this Agreement, be free
of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names
as any Purchaser may request and maintain a transfer agent for the Common Stock.


 


5.2.3      Obligations
and Acknowledgements of the Purchasers.  In connection with the registration of the Registrable Securities, each
Purchaser shall have the following obligations and hereby make the following acknowledgements:


 


(a)      It
shall be a condition precedent to the obligations of the Company to include the Registrable Securities in the Registration Statement
that each Purchaser wishing to participate in the Registration Statement (i) shall furnish to the Company such information regarding
itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it
as shall be reasonably required to effect the registration of such Registrable Securities and (ii) shall execute such documents
in connection with such registration as the Company may reasonably request.  Prior to the first anticipated filing date
of a Registration Statement, the Company shall notify each Purchaser of the information the Company requires from such Purchaser
(the “Requested Information”) if such Purchaser elects to have any of its Registrable Securities included in
the Registration Statement.  If a Purchaser notifies the Company and provides the Company the information required hereby
prior to the time the Registration Statement is declared effective, the Company will file an amendment to the Registration Statement
that includes the Registrable Securities of such Purchaser provided, however, that the Company shall not be required
to file such amendment to the Registration Statement at any time less than five (5) business days prior to the effective date.


 


(b)      Each
Purchaser agrees to cooperate with the Company in connection with the preparation and filing of a Registration Statement hereunder,
unless such Purchaser has notified the Company in writing of its election to exclude all of its Registrable Securities from such
Registration Statement;


 


(c)      Each
Purchaser agrees that, upon receipt of any notice from the Company of the occurrence of any event of the kind described in Section
5.2.2(e) or 5.2.2(f), such Purchaser shall immediately discontinue its disposition of Registrable Securities pursuant to the Registration
Statement covering such Registrable Securities until the Purchaser’s receipt of the copies of the supplemented or amended
Prospectus contemplated by Section 5.2.2(e) and, if so directed by the Company, the Purchaser shall deliver to the Company (at
the expense of the Company) or destroy (and deliver to the Company a certificate of destruction) all copies in the Purchaser’s
possession, of the Prospectus covering such Registrable Securities current at the time of receipt of such notice; and


 


(d)      Each
Purchaser acknowledges that it may be deemed to be a statutory underwriter within the meaning of the Securities Act with respect
to the Registrable Securities being registered for resale by it, and if a Purchaser includes Registrable Securities for offer
and sale within a Registration Statement such Purchaser hereby consents to the inclusion in such Registration Statement of a disclosure
to such effect.


 


5.2.4      Expenses
of Registration.  All expenses (other than underwriting discounts and commissions and the fees and expenses of a
Purchaser’s counsel) incurred in connection with registrations, filings or qualifications pursuant to this Section 5.2,
including, without limitation, all registration, listing, and qualifications fees, printing and engraving fees, accounting fees,
and the fees and disbursements of counsel for the Company, shall be borne by the Company.


 






    	 	7	 



     


    

 


5.2.5      Indemnification
and Contribution.


 


(a)         Indemnification
by the Company.  The Company shall indemnify and hold harmless each Purchaser and each underwriter, if any, which
facilitates the disposition of Registrable Securities, and each of their respective officers and directors and each Person who
controls such underwriter within the meaning of Section 15 of the Securities Act or Section 20 of the 1934 Act (each such Person
being sometimes hereinafter referred to as an “Indemnified Person”) from and against any losses, claims, damages
or liabilities, joint or several, to which such Indemnified Person may become subject under the Securities Act or otherwise, insofar
as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an untrue statement
or alleged untrue statement of a material fact contained in any Registration Statement or an omission or alleged omission to state
therein a material fact required to be stated therein or necessary to make the statements therein, not misleading, or arise out
of or are based upon an untrue statement or alleged untrue statement of a material fact contained in any Prospectus or an omission
or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading; and the Company hereby agrees to reimburse such
Indemnified Person for all reasonable legal and other expenses incurred by them in connection with investigating or defending
any such action or claim as and when such expenses are incurred; provided, however, that the Company shall not be liable to any
such Indemnified Person in any such case to the extent that any such loss, claim, damage or liability arises out of or is based
upon (i) an untrue statement or alleged untrue statement made in, or an omission or alleged omission from, such Registration Statement
or Prospectus in reliance upon and in conformity with written information furnished to the Company by such Indemnified Person
expressly for use therein or (ii) in the case of the occurrence of an event of the type specified in Section 5.2.2(e), the use
by the Indemnified Person of an outdated or defective Prospectus after the Company has provided to such Indemnified Person an
updated Prospectus correcting the untrue statement or alleged untrue statement or omission or alleged omission giving rise to
such loss, claim, damage or liability.


 


(b)     Indemnification
by the Purchasers and Underwriters.  Each Purchaser agrees, as a consequence of the inclusion of any of its Registrable
Securities in a Registration Statement, and each underwriter, if any, which facilitates the disposition of Registrable Securities
shall agree, severally and not jointly, as a consequence of facilitating such disposition of Registrable Securities to (i) indemnify
and hold harmless the Company, its directors (including any person who, with his or her consent, is named in the Registration
Statement as a director nominee of the Company), its officers who sign any Registration Statement and each Person, if any, who
controls the Company within the meaning of either Section 15 of the Securities Act or Section 20 of the 1934 Act, against any
losses, claims, damages or liabilities to which the Company or such other persons may become subject, under the Securities Act
or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based
upon an untrue statement or alleged untrue statement of a material fact contained in such Registration Statement or Prospectus
or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein
or necessary to make the statements therein (in light of the circumstances under which they were made, in the case of the Prospectus),
not misleading, in each case to the extent, but only to the extent, that such untrue statement or alleged untrue statement or
omission or alleged omission was made in reliance upon and in conformity with written information furnished to the Company by
the Purchaser or underwriter expressly for use therein, and (ii) reimburse the Company for any legal or other expenses incurred
by the Company in connection with investigating or defending any such action or claim as such expenses are incurred; provided,
however, that such Purchaser shall not be liable under this Section 5.2.5(b) for any amount in excess of the net proceeds paid
to such Purchaser in respect of Registrable Securities sold by it.


 


(c)      Notice
of Claims, etc.  Promptly after receipt by a Person seeking indemnification pursuant to this Section 5.2.5 (an “Indemnified
Party”) of written notice of any investigation, claim, proceeding or other action in respect of which indemnification
is being sought (each, a “Claim”), the Indemnified Party promptly shall notify the Person against whom indemnification
pursuant to this Section 5.2.5 is being sought (the “Indemnifying Party”) of the commencement thereof; but
the omission to so notify the Indemnifying Party shall not relieve it from any liability that it otherwise may have to the Indemnified
Party, except to the extent that the Indemnifying Party is materially prejudiced and forfeits substantive rights and defenses
by reason of such failure.  In connection with any Claim as to which both the Indemnifying Party and the Indemnified
Party are parties, the Indemnifying Party shall be entitled to assume the defense thereof.  Notwithstanding the assumption
of the defense of any Claim by the Indemnifying Party, the Indemnified Party shall have the right to employ separate legal counsel
and to participate in the defense of such Claim, and the Indemnifying Party shall bear the reasonable fees, out of pocket costs
and expenses of such separate legal counsel to the Indemnified Party if (and only if): (i) the Indemnifying Party shall have agreed
to pay such fees, costs and expenses, (ii) the Indemnified Party shall reasonably have concluded that representation of the Indemnified
Party by the Indemnifying Party by the same legal counsel would not be appropriate due to actual or, as reasonably determined
by legal counsel to the Indemnified Party, potentially differing interests between such parties in the conduct of the defense
of such Claim, or if there may be legal defenses available to the Indemnified Party that are in addition to or disparate from
those available to the Indemnifying Party, or (iii) the Indemnifying Party shall have failed to employ legal counsel reasonably
satisfactory to the Indemnified Party within a reasonable period of time after notice of the commencement of such Claim.  If
the Indemnified Party employs separate legal counsel in circumstances other than as described in the preceding sentence, the fees,
costs and expenses of such legal counsel shall be borne exclusively by the Indemnified Party. Except as provided above,
the Indemnifying Party shall not, in connection with any Claim in the same jurisdiction, be liable for the fees and expenses of
more than one firm of counsel for the Indemnified Party (together with appropriate local counsel).  The Indemnified
Party shall not, without the prior written consent of the Indemnifying Party (which consent shall not unreasonably be withheld),
settle or compromise any Claim or consent to the entry of any judgment that does not include an unconditional release of the Indemnifying
Party from all liabilities with respect to such Claim or judgment or contain any admission of wrongdoing.


 






    	 	8	 



     


    

 


(d)     Contribution.  If
the indemnification provided for in this Section 5.2.5 is unavailable to or insufficient to hold harmless an Indemnified Party
in respect of any losses, claims, damages or liabilities (or actions in respect thereof) referred to therein, then each Indemnifying
Party shall contribute to the amount paid or payable by such Indemnified Party as a result of such losses, claims, damages or
liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect the relative fault of the Indemnifying
Party and the Indemnified Party in connection with the statements or omissions or alleged statements or omissions which resulted
in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable considerations.  The
relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether
the untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to
information supplied by such Indemnifying Party or by such Indemnified Party, and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission.  The parties hereto agree that
it would not be just and equitable if contribution pursuant to this Section 5.2.5(d) were determined by pro rata allocation (even
if the Purchasers or any underwriters were treated as one entity for such purpose) or by any other method of allocation which
does not take account of the equitable considerations referred to in this Section 5.2.5(d).  The amount paid or payable
by an Indemnified Party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to
above shall be deemed to include any legal or other fees or expenses reasonably incurred by such Indemnified Party in connection
with investigating or defending any such action or claim.  No person guilty of fraudulent misrepresentation (within
the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation.


 


(e)      Limitation
on Purchasers’ and Underwriters’ Obligations.  Notwithstanding any other provision of this Section 5.2.5,
in no event shall (i) any Purchaser have any liability under this Section 5.2.5 for any amounts in excess of the dollar amount
of the proceeds actually received by such Purchaser from the sale of Registrable Securities (after deducting any fees, discounts
and commissions applicable thereto) pursuant to any Registration Statement under which such Registrable Securities are registered
under the Securities Act and (ii) any underwriter be required to undertake liability to any Person hereunder for any amounts in
excess of the aggregate discount, commission or other compensation payable to such underwriter with respect to the Registrable
Securities underwritten by it and distributed pursuant to the Registration Statement.


 


(f)       Other
Liabilities.  The obligations of the Company under this Section 5.2.5 shall be in addition to any liability which
the Company may otherwise have to any Indemnified Person and the obligations of any Indemnified Person under this Section 5.2.5
shall be in addition to any liability which such Indemnified Person may otherwise have to the Company. The remedies
provided in this Section 5.2.5 are not exclusive and shall not limit any rights or remedies which may otherwise be available to
an indemnified party at law or in equity.


 






    	 	9	 



     


    

 


5.2.6      Common
Stock Issued Upon Stock Split, etc.  The provisions of this Section 5.2 shall apply to any shares of Common Stock
or any other securities issued as a dividend or distribution in respect of the Shares.


 


5.2.7      Termination
of Registration Rights.  The registration rights granted in this Section 5.2 shall terminate with respect to a security
upon the date such security is first eligible to be resold pursuant to Rule 144 of the Securities Act.


 


5.3        Payment
for Legal Opinions and Removal of Legends.  The Company shall cover all costs associated with removal of any Securities
Act restrictive legends, including, without limitation, the cost of replacement certificates and opinion or letter of Company
counsel to the transfer agent, as well as delivery costs, for all Shares.


 


5.4        Listing
of Common Stock. The Company hereby agrees to use best efforts to maintain the listing or quotation of the Common Stock on
the Nasdaq Capital Market (“Nasdaq”) or other securities exchange (“Trading Market”), and
concurrently with the Closing, the Company shall apply, if required, to list all of the Shares on Nasdaq and promptly secure the
listing of all of the Shares on Nasdaq. The Company further agrees, if the Company applies to have the Common Stock traded on
any other Trading Market, it will then include in such application all of the Shares, and will take such other action as is necessary
to cause all of the Shares to be listed on Nasdaq or such other Trading Market as promptly as possible.  The Company
will then take all action reasonably necessary to continue the listing or quotation and trading of its Common Stock on a Trading
Market and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules
of such Trading Market.


  


5.5        Equal
Treatment of Purchasers.  No consideration (including any modification of this Agreement) shall be offered or paid
to any Person to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration
is also offered to all of the parties to this Agreement.  For clarification purposes, this provision constitutes a separate
right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to
treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a group with respect
to the purchase, disposition or voting of Securities or otherwise.


 


5.6         Form
D; Blue Sky Filings.  The Company agrees to timely file a Form D with respect to the Securities as required under
Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the
Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to
the Purchasers at the Closing under applicable securities or “Blue Sky” laws of the states of the United States, and
shall provide evidence of such actions promptly upon request of any Purchaser.


 


5.7        Independent
Nature of Purchasers’ Obligations and Rights.  The obligations of each Purchaser under this Agreement are
several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
or non-performance of the obligations of any other Purchaser under this Agreement.  This Agreement shall constitute
an agreement between each Purchaser and the Company and each Purchaser and not as an agreement between or among the Purchasers.  Nothing
contained herein, and no action taken by any Purchaser pursuant hereof or thereto, shall be deemed to constitute (a) any agreement
between or among the Purchasers or to create any rights or obligations between or among the Purchasers, each of whom is acting
independently in entering into this Agreement or (b) the Purchasers as a partnership, an association, a joint venture or any other
kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such
obligations or the transactions contemplated by this Agreement.  Each Purchaser shall be entitled to independently protect
and enforce its rights, including, without limitation, the rights arising out of this Agreement, and it shall not be necessary
for any other Purchaser to be joined as an additional party in any proceeding for such purpose.


 






    	 	10	 



     


    

 


6.          CONDITIONS


 


6.1         Conditions
Precedent to the Obligation of the Company to Close and to Sell the Shares.  The obligation hereunder of the Company
to close and issue and sell the Shares to the Purchasers at a Closing is subject to the satisfaction or waiver, at or before such
Closing of the conditions set forth below.  These conditions are for the Company’s sole benefit and may be waived
by the Company at any time in its sole discretion.


 


6.1.1      Accuracy
of the Purchasers’ Representations and Warranties.  The representations and warranties of each Purchaser (including,
for avoidance of doubt, those relating to the Questionnaire) shall be true and correct in all material respects as of the date
when made and as of such Closing as though made at that time, except for representations and warranties that are expressly made
as of a particular date, which shall be true and correct in all material respects as of such date.


 


6.1.2      Performance
by the Purchasers.  Each Purchaser shall have performed, satisfied, and complied in all material respects with all
covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Purchasers
at or prior to such Closing.


 


6.1.3      No
Injunction.  No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of any of the transactions contemplated by this Agreement.


 


6.1.4      Delivery
of Purchase Price.  The Purchase Price for the Shares shall be available in cleared funds on such Closing.


 


6.1.5      Delivery
of Transaction Documents.  The Transaction Documents shall have been duly executed and delivered by the Purchasers
to the Company.


 


6.2        Conditions
Precedent to the Obligation of the Purchasers to Close and to Purchase the Shares.  The obligation hereunder of
the Purchasers to purchase the Shares and consummate the transactions contemplated by this Agreement is subject to the satisfaction
or waiver, at or before such Closing, of each of the conditions set forth below.  These conditions are for the Purchasers’
sole benefit and may be waived by the Purchasers at any time in their sole discretion.


 


6.2.1      Accuracy
of the Company’s Representations and Warranties.  Each of the representations and warranties of the Company
in this Agreement and the other Transaction Documents shall be true and correct in all respects as of such Closing, except for
representations and warranties that speak as of a particular date, which shall be true and correct in all respects as of such
date.


 


6.2.2      Performance
by the Company.  The Company shall have performed, satisfied and complied in all material respects with all covenants,
agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to
such Closing.


 


6.2.3      No
Suspension.  Trading in the Common Stock of the Company shall not have been suspended by the SEC, Nasdaq or other
exchange or quotation system (except for any suspension of trading of limited duration agreed to by the Company, which suspension
shall be terminated prior to the Closing).


 


6.2.4      No
Injunction.  No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted,
entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction which prohibits the consummation
of any of the transactions contemplated by this Agreement.


 


6.2.5      No
Proceedings or Litigation.  No action, suit or proceeding before any arbitrator or any governmental authority shall
have been commenced, and no investigation by any governmental authority shall have been initiated, against the Company, or any
of the officers, directors or affiliates of the Company seeking to restrain, prevent or change the transactions contemplated by
this Agreement, or seeking damages in connection with such transactions.


 






    	 	11	 



     


    

 


6.2.6      Shares.  Within
five business days of Closing, the Company shall have delivered to the Purchasers the Shares.  The Company shall also
deliver this Agreement, duly executed by the Company.


 


7.          MISCELLANEOUS.


 


7.1         Indemnification.  Each
Purchaser agrees to defend, indemnify and hold the Company harmless against any liability, costs or expenses arising as a result
of any dissemination of any of the Securities by such Purchaser in violation of the Securities Act or applicable state securities
law.


 


7.2         Governing
Law.  The validity and interpretation of this Agreement shall be governed by, and construed and enforced in accordance
with, the laws of the State of New York.  Each of the parties hereto and their assigns hereby consents to the exclusive
jurisdiction and venue of the Courts of the State of New York, located in the City and County of New York and the United States
District Court, Southern District, for the State of New York with respect to any matter relating to this Agreement and performance
of the parties’ obligations hereunder, the documents and instruments executed and delivered concurrently herewith or pursuant
hereto and performance of the parties’ obligations thereunder and each of the parties hereto hereby consents to the personal
jurisdiction of such courts and shall subject itself to such personal jurisdiction.  Any action, suit or proceeding
relating to such matters shall be commenced, pursued, defended and resolved only in such courts and any appropriate appellate
court having jurisdiction to hear an appeal from any judgment entered in such courts.  The parties irrevocably waive
the defense of an inconvenient forum to the maintenance of such suit or proceeding.  Service of process in any action,
suit or proceeding relating to such matters may be made and served within or outside the State of New York by registered or certified
mail to the parties and their representatives at their respective addresses specified in Section 7.7, provided that a reasonable
time, not less than thirty (30) days, is allowed for response.  Service of process may also be made in such other manner
as may be permissible under the applicable court rules.  THE PARTIES HERETO WAIVE TRIAL BY JURY.


 


7.3        Successors
and Assigns.  Except as otherwise expressly provided herein, the provisions hereof shall inure to the benefit of,
and be binding upon, the successors, assigns, heirs, executors, and administrators of the parties hereto.


 


7.4        Entire
Agreement.  This Agreement and the Exhibits hereto and thereto, and the other documents delivered pursuant hereto
and thereto, constitute the full and entire understanding and agreement among the parties with regard to the subjects hereof and
no party shall be liable or bound to any other party in any manner by any representations, warranties, covenants, or agreements
except as specifically set forth herein or therein.  Nothing in this Agreement, express or implied, is intended to confer
upon any party, other than the parties hereto and their respective successors and assigns, any rights, remedies, obligations,
or liabilities under or by reason of this Agreement, except as expressly provided herein.


 


7.5         Severability.  In
case any provision of this Agreement shall be invalid, illegal, or unenforceable, it shall to the extent practicable, be modified
so as to make it valid, legal and enforceable and to retain as nearly as practicable the intent of the parties, and the validity,
legality, and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.


 


7.6         Amendment
and Waiver.  Except as otherwise provided herein, any term of this Agreement may be amended, and the observance
of any term of this Agreement may be waived (either generally or in a particular instance, either retroactively or prospectively,
and either for a specified period of time or indefinitely), with the written consent of the Company and holders of a majority
of the Shares, or, to the extent such amendment affects only one Purchaser, by the Company and such Purchaser.  Any
amendment or waiver effected in accordance with this Section 7.6 shall be binding upon each future holder of any security purchased
under this Agreement (including securities into which such securities have been converted) and the Company.


 






    	 	12	 



     


    

 


7.7        Notices.  All
notices and other communications required or permitted hereunder shall be in writing and shall be effective when delivered personally,
or sent by telex or telecopier (with receipt confirmed), provided that a copy is mailed by registered mail, return receipt requested,
or when received by the addressee, if sent by Federal Express or other express delivery service (receipt requested) in each case
to the appropriate address set forth below:


 


	If to the Company:	 

        MYOS
        RENS Technology Inc.

	 	45 Horsehill Road, Suite 106
	 	Cedar Knolls, New Jersey 07927
	 	Attention:  Chief Executive Officer
	 	 
	With a copy to:	Ellenoff Grossman & Schole LLP
	 	1345 Avenue of the Americas
	 	New York, New York 10105
	 	Facsimile: (212) 370-7889
	 	Attention:  Stuart Neuhauser, Esq.
    and Joshua Englard, Esq.
	 	 
	If to the Purchaser:	At the address set forth on the Purchaser’s
    Signature Page
	 	 


 


7.8         Faxes,
Electronic Mail and Counterparts.  This Agreement may be executed in one or more counterparts.  Delivery
of an executed counterpart of the Agreement or any exhibit attached hereto by facsimile transmission or electronic mail (any such
delivery, an “Electronic Delivery”), shall be treated in all manner and respects as an original agreement or
instrument and shall be considered to have the same binding legal effect as if it were the original signed version thereof delivered
in person.  At the request of any party hereto, each other party hereto shall re-execute original forms hereof and deliver
them in person to all other parties.  No party hereto shall raise the use of Electronic Delivery to deliver a signature
or the fact that any signature or agreement or instrument was transmitted or communicated through the use of Electronic Delivery
as a defense to the formation of a contract, and each such party forever waives any such defense, except to the extent such defense
related to lack of authenticity.


 


7.9        Titles
and Subtitles.  The titles of the paragraphs and subparagraphs of this Agreement are for convenience of reference
only and are not to be considered in construing this Agreement.


 


7.10      Further
Assurances.  At any time and from time to time after the Closing, upon reasonable request of the other, each party
shall do, execute, acknowledge and deliver such further acts, assignments, transfers, conveyances and assurances as may be reasonably
required for the more complete consummation of the transactions contemplated herein.


 


7.11       Legal
Fees.  In the event any suit or other legal proceeding is brought for the enforcement of any of the provisions of
this Agreement, the parties hereto agree that the prevailing party or parties shall be entitled to recover from the other party
or parties upon final judgment on the merits reasonable attorneys’ fees, including attorneys’ fees for any appeal,
and costs incurred in bringing such suit or proceeding.


 


*********************


 









    	 	13	 



     


    

 


[Counterpart
Signature Page To MYOS RENS Technology Inc. Securities Purchase


Agreement]


 


IN
WITNESS WHEREOF, the parties have executed this Agreement as of the date set forth on the Purchase Signature Page hereto.


 


	 	PURCHASER
	 	 
	 	 
	 	(By Counterpart Form - See Purchaser Signature
    Pages following the Questionnaire)
	 	 
	 	COMPANY
	 	 
	 	MYOS RENS TECHNOLOGY INC.
	 	(By Execution of Acceptance Page following Certificate
    of Signatory)


  




    	 	14	 



     


    

 


PURCHASER
SIGNATURE PAGES


 


The
undersigned Purchaser has read the Securities Purchase Agreement of MYOS RENS Technology Inc., a Nevada corporation dated as of
April 25, 2018, and acknowledges that the completion of this Questionnaire and the execution of the Purchaser Signature Page that
follows shall constitute the undersigned’s execution of such Agreement.  This Questionnaire is and shall remain
part of the Agreement.  All capitalized terms used herein shall be as defined in such Agreement


 


I
hereby subscribe for ____ Shares, at a Purchase Price of $1.24 per Share. The aggregate Purchase Price of the Shares is $                               .  


 


I
am a resident of the State(s) or Country of ______________ and                                       .


 


                                                                                                                                               


 


Please
print above the exact name(s) in which the Shares are to be held


 


My
address is:                                                                                                                              


 


                                                                                                                            


 


                                                                                                                            


 


My
phone number is:                                                                                                                  


 


 


[Continued]


 






 




    	 	15	 



     


    

 


ACCREDITED
INVESTOR QUESTIONNAIRE


Offering
of Shares


 


I
acknowledge that the offering of the Shares is subject to the Federal securities laws of the United States and state securities
laws of those states in which the Shares are offered, and that, pursuant to the U.S. Federal securities laws and state securities
laws, the Shares may be purchased by persons who come within the definition of an “Accredited Investor” as
that term is defined in Rule 501(a) of Regulation D promulgated under the Securities Act (“Regulation D”).


 


By
initialing one of the categories below, I represent and warrant that I come within the category so initialed and have truthfully
set forth the factual basis or reason I come within that category.  All information in response to this paragraph will
be kept strictly confidential.  I agree to furnish any additional information that the Company deems necessary in order
to verify the answers set forth below.


 


NOTE:  You
must initial at least ONE category.


 


Individual
Purchaser:


(A
Purchaser who is an individual may initial either Category I, II, or III)


 


	Category I   ______	I
                           am a director or executive officer of the Company.

         

	Category II ______	I
        am an individual (not a partnership, corporation, etc.) whose individual net worth, or joint net worth with my spouse,
        presently exceeds $1,000,000.*

         

        Explanation.  In
        calculation of net worth, you may include equity in personal property and real estate other than your principal
        residence, including cash, short term investments, stocks and securities.  Equity in personal property
        and real estate should be based on the fair market value of such property less debt secured by such property.

         

	Category III ______	I am an individual (not a partnership, corporation,
    etc.) who had an individual income in excess of $200,000 in 2016 and 2017, or joint income with my spouse in excess of $300,000
    in 2016 and 2017, and I have a reasonable expectation of reaching the same income level in 2018.**





 


 






*
For purposes of this Accredited Investor Questionnaire, “net worth” means the excess of total assets at fair
market value, including cash, stock, securities, personal property and real estate (other than your primary residence), over total
liabilities (other than a mortgage or other debt secured by your primary residence). In the event that the amount of any mortgage
or other indebtedness secured by your primary residence exceeds the fair market value of the residence, that excess liability
should also be deducted from your net worth. Any mortgage or indebtedness secured by your primary residence incurred within 60
days before the time of the sale of the securities offered hereunder, other than as a result of the acquisition of the primary
residence, shall also be deducted from your net worth.


 


 **  For
purposes of this Accredited Investor Questionnaire, individual income means adjusted gross income, as reported for federal income
tax purposes, less any income attributable to a spouse or to property owned by a spouse, increased by the following amounts (but
not including any amounts attributable to a spouse or to property owned by a spouse): (i) the amount of any tax-exempt interest
income under Section 103 of the Internal Revenue Code of 1986, as amended (the “Code”), received; (ii) the
amount of losses claimed as a limited partner in a limited partnership as reported on Schedule E of Form 1040; (iii) any deduction
claimed for depletion under Section 611 et seq. of the Code; (iv) amounts contributed to an Individual Retirement Account (as
defined in the Code) or Keogh retirement plan; (v) alimony paid;(vi) any elective contributions to a cash or deferred arrangement
under Section 401(k) of the Code; and (vii) for applicable taxable years, any amount by which income from long-term capital gains
has been reduced in arriving at adjusted gross income pursuant to the provisions of Section 1202 of the Code.


 




    	 	16	 



     


    

 


Entity
Purchasers:


 


(A
Purchaser which is a corporation, limited liability company, partnership, trust, or other entity may initial either
Category IV, V, VI, VII or VIII)


 


	Category IV ______	The
                           Purchaser is an entity in which all of the equity owners are “Accredited Investors”
                           as defined in Rule 501(a) of Regulation D.  If relying upon this category alone, each
                           equity owner must complete a separate copy of this Agreement.

         

	 	 
	 	 
	 	 
	 	(describe
        entity)

         

	Category V  ______	The
        Purchaser is a trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the
        Shares offered, whose purchase is directed by a “Sophisticated Person” as described in Rule 506(b)(2)(ii)
        of Regulation D.

         

	Category VI  ______	The
        Purchaser is an organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or
        similar business trust, or partnership, not formed for the specific purpose of acquiring the Shares, with total assets
        in excess of $5,000,000.

         

	 	 
	 	 
	 	 
	 	(describe entity)


 


	 Category VII  ______	The
                           Purchaser is a private business development company as defined in Section 202(a)(22) of the Investment
                           Advisers Act of 1940.

         

	 	 
	 	 
	 	 
	 	(describe entity)
	 	 
	Category VIII  _____	Any
bank as defined in section 3(a)(2) of the Securities Act of 1933, as amended (“Act”), or any savings and loan
association or other institution as defined in section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity;
any broker or dealer registered pursuant to section 15 of the Securities Exchange Act of 1934, as amended; any insurance company
as defined in section 2(a)(13) of the Act; any investment company registered under the Investment Company Act of 1940 or a business
development company as defined in section 2(a)(48) of that Act; any Small Business Investment Company licensed by the U.S. Small
Business Administration under section 301(c) or (d) of the Small Business Investment Act of 1958; any plan established and maintained
by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit
of its employees, if such plan has total assets in excess of $5,000,000; any employee benefit plan within the meaning of the Employee
Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary, as defined in section 3(21) of
such act, which is either a bank, savings and loan association, insurance company, or registered investment adviser, or if the
employee benefit plan has total assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely
by persons that are accredited investors;

	 	 
	 	 
	 	 
	 	 
	 	(describe entity)


 


Executed
this _____ day of  _________, 2018 at ____________________, ________________.


 


[Continued]


  




    	 	17	 



     


    

 


PURCHASER
SIGNATURE PAGE


(For
Individual Purchasers)


 


This
Securities Purchase Agreement of MYOS RENS Technology Inc. (including the Questionnaire) is hereby executed and entered into by
the below Purchaser.


 


	 

        No.
        of Shares: __________(@$1.24 per Share)

         

        Aggregate
        Purchase Price $_____________
	____________________________________

        Signature
        (Individual)

         

        ____________________________________

        Name
        (Print)

         

        ____________________________________

        Street
        address

         

        ____________________________________

        City,
        State, Zip Code & Country

         

	 	_____________________________________

        Tax
        Identification or Social Security Number

         

        (            )                                                                

        Telephone
        Number

         

        (            )                                                                

        Facsimile
        Number

         

	 	Address
        to Which Correspondence Should Be Directed 

(if different from above)

         

        ____________________________________

        c/o
        Name

         

        ____________________________________

        Street
        Address

	 	 

        ___________________________________

        City,
        State, Zip Code & Country

         

        

        (            )                                                                

        Telephone
        Number

         

        (            )                                                                

        Facsimile
        Number



  




    	 	18	 



     


    

 


PURCHASER
SIGNATURE PAGE


(for
Corporation, Partnership, Trust or Other Entities)


 


This
Securities Purchase Agreement of MYOS RENS Technology Inc. (including the Questionnaire) is hereby executed and entered into by
the below Purchaser:


 


	 

        No.
        of Shares: __________(@$1.24 per Share)

         

        Aggregate
        Purchase Price $_____________
	____________________________________

        Signature
        (Individual)

         

        ____________________________________

        Name
        (Print)

         

        ____________________________________

        Street
        address

         

        ____________________________________

        City,
        State, Zip Code & Country

         

	 	____________________________________

        Tax
        Identification or Social Security Number

         

        (            )                                                                

        Telephone
        Number

         

        (            )                                                                

        Facsimile
        Number

         

	 	Address
        to Which Correspondence Should Be Directed

                                                         (if different from above)

         

        ____________________________________

        c/o
        Name

         

        ____________________________________

        Street
        Address

	 	 

        ___________________________________

        City,
        State, Zip Code & Country

         

        

        (            )                                                                

        Telephone
        Number

         

        (            )                                                                

        Facsimile
        Number



 


*If
Shares are being subscribed for by an entity, the Certificate of Signatory that follows must also be completed.


  




    	 	19	 



     


    

 


CERTIFICATE
OF SIGNATORY


 


(To
be completed if Shares are being subscribed for by an entity)


 


I,__________________________________,
am the ___________________________ of __________________________________________ (the “Entity”).


 


I
certify that I am empowered and duly authorized by the Entity to execute and carry out the terms of the Securities Purchase Agreement
and to purchase and hold the Shares.  The Securities Purchase Agreement has been duly and validly executed on behalf
of the Entity and constitutes a legal and binding obligation of the Entity.


 


IN
WITNESS WHEREOF, I have hereto set my hand this _____ day of April, 2018.


 


	 	_________________________________________________

        Signature



  




    	 	20	 



     


    

 


 


ACCEPTANCE
PAGE TO SECURITIES PURCHASE AGREEMENT OF


MYOS
RENS TECHNOLOGY INC.


 


The
foregoing subscriptions for _______________ Shares, for an aggregate purchase price of $_______________ at a Purchase Price of
$1.24 per Share, in accordance with the foregoing Securities Purchase Agreement, AGREED AND ACCEPTED; provided, however,
that the Company may accept additional subscriptions from time to time without consent of Purchasers until the maximum offering
amount is accepted and Closed upon, in accordance with this Agreement:


 


	MYOS RENS TECHNOLOGY INC.	 
	 	 
	By:	 	 
	Name:	 Joseph Mannello	 
	Title:	Chief Executive Officer	 


 


Date:  ___________________,
2018


 


 


21